Cubist Systematic Strategies’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,600
Closed -$371K 3042
2024
Q4
$371K Hold
6,600
﹤0.01% 2307
2024
Q3
$450K Buy
+6,600
New +$372K ﹤0.01% 2256
2024
Q2
Sell
-4,200
Closed -$290K 3287
2024
Q1
$290K Sell
4,200
-100
-2% -$6.33K ﹤0.01% 2894
2023
Q4
$318K Hold
4,300
﹤0.01% 2769
2023
Q3
$293K Buy
+4,300
New +$365K ﹤0.01% 2609

Other funds holding EXAS

Cubist Systematic Strategies's EXAS Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Exact Sciences (EXAS) stake by 47% in Q3 2025, selling an estimated $3.63M and leaving 82,441 shares worth $4.51M. The position accounts for 0.02% of the portfolio, ranked #1024.

Cubist Systematic Strategies first reported a position in EXAS in Q1 2015 and has held it in 35 quarters since. The position peaked at $20.5M in Q2 2023. 568 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

  • Cubist Systematic Strategies held 82,441 shares of Exact Sciences worth $4.51M as of Q3 2025.
  • Cubist Systematic Strategies sold 72,716 Exact Sciences shares in Q3 2025, an estimated $3.63M.
  • Exact Sciences made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1024 holding.
  • Cubist Systematic Strategies first reported a position in Exact Sciences in Q1 2015 and has held it in 35 quarters since.
  • Cubist Systematic Strategies's Exact Sciences position peaked at $20.5M in Q2 2023.
  • 568 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.